"PASSIVE" STENT COATING PASSES RABBIT PYROGEN TEST.

Biotech Equipment Update, August, 2004

MIV Therapeutics Inc. (MIVT:OTCBB), Vancouver, has announced that its proprietary Hydroxyapatite (HAp) ultra-thin "passive" stent coating has successfully passed the Rabbit Pyrogen Test (Material Mediated) - ISO confirming that the coating is non- pyrogenic and does not induce fever.

Biocompatibility is one of the key features that differentiate MIVT's proprietary HAp coating technology. Dr. Tom Troczynski, MIVT's vice president of Coatings commented, "There is an extensive range of biocompatibility tests performed on cardiovascular stents coated with our proprietary coating technology that include a variety of short and long term assessments. In their totality, this range of tests is expected to confirm total biocompatibility of our proprietary HAp coating...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.